期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

卡维地洛治疗慢性充血性心力衰竭的疗效观察

下载PDF
导出
摘要 目的:观察卡维地洛在治疗慢性充血性心力衰竭患者的疗效。方法:将78例心衰患者随机分为两组,对照组:常规应用强心剂、利尿剂、血管扩张剂。治疗组:在常规治疗的基础上加用卡维地洛,从小剂量开始,3.125mg/次,每日2次,每2周递增1次,逐渐增至25mg/次,每日2次,维持治疗6个月,测量两组治疗前后6个月超声心动图、静息心率及运动耐量试验。结果:与对照组相比,治疗6个月后超声心动图指标明显改善,运动耐量明显提高。结论:卡维地洛能明显减缓慢性心衰患者的进展,有显著疗效。
作者 杜青 朱新香
机构地区 青海省格尔木市海西州第二人民医院药剂科
出处 《青海医药杂志》 2008年第11期19-20,共2页 Qinghai Medical Journal
关键词 心力衰竭 卡维地洛 超声心动图 运动耐量
分类号 R541.61 [医药卫生—心血管疾病]
  • 相关文献

参考文献6

二级参考文献25

  • 1[1]CIBIS-Ⅱ Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study Ⅱ (CIBIS Ⅱ): a randomized trial. Lancet, 1999,353: 9-13.
  • 2[2]MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet, 1999, 353:2001-2007.
  • 3[3]Packer M, Coats AJS, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med, 2001,344:1651-1658.
  • 4[5]Packer M, Cohn JN, Abraham WT, et al. Consensus recommendations for management of chronic heart failure. Am J Cardiol, 1999, 83:1A-38A.
  • 5[6]Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology. Guidelines for the diagnosis and treartment of chronic heart failure. Eur Heart J,2001, 22:1527-1560.
  • 6[7]Bristow MR, Gilbert EM, Abraham WT, et al. Carvediol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. Circulation,1996, 94:2807-2816.
  • 7[8]Wikstrand J, Hjalmarson A, Waagstein F, et al. Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure. Analysis of the experience in Metoprolol CR/XL Randomized International Trial in Chronic Heart Failure (MERIT-HF). J Am Coll Cardiol, 2002, 40:491-498.
  • 8[9]Simon T, Mary-Krause M, Furck-Brentano C, et al. Bisoprolol dose-response relationship in patients with congestive heart failure: a subgpoup analysis in the cardiac insufficiency bisoprolol study (CIBIS Ⅱ ). Eur Heart J, 2003, 24:552-559.
  • 9[10]Poole-Wilson PA, Cleland JGF, Lenarda AD, et al. Rationale and design of the carvedilol or metoprolol European trial in patients with chronic heart failure: COMET. Eur J Heart Fail,2002, 4:321-329.
  • 10[11]Poole-Wilson PA, Swedberg K, Cleland JGF, et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European Trial (COMET): randomised controlled trial. Lancet, 2003, 362:7-13.

共引文献1474

青海医药杂志
2008年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部